TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026)

TherapeuticsMD (TXMD) has reported Change in Account Payables for 17 consecutive years, with $423000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Account Payables rose 143.1% year-over-year to $423000.0; the trailing twelve-month figure through Jun 2026 stood at $110000.0 (down 46.86% YoY), and the FY2025 full-year result was $119000.0, down 48.48% from the prior year.
• Change in Account Payables advanced to $423000.0 in Q2 2026 per TXMD's latest filing, from -$340000.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $423000.0 in Q2 2026 and bottomed at -$818000.0 in Q2 2023.
• Historically, Change in Account Payables has averaged -$161833.3 across 5 years, with a median of -$39000.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Change in Account Payables slumped 946.84% in 2023, then jumped 4250.0% in 2025.
• Over 5 years, Change in Account Payables stood at $79000.0 in 2022, then plunged by 946.84% to -$669000.0 in 2023, then soared by 103.59% to $24000.0 in 2024, then jumped by 375.0% to $114000.0 in 2025, then soared by 271.05% to $423000.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $423000.0, -$340000.0, and $114000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.